// App-Quantinova.ai

18079 : B-Type Natriuretic Peptide is a Screening Tool to Rule Out Subclinical Left Ventricular Geometry and Diastolic Dysfunction in a Community-Based Population

Researchers

Presenter

  • Masanori Asakura

Principal Investigators

  • Hideaki Kanzaki

  • Jiyoong Kim

  • Hiroshi Asanuma

  • Akira Funada

  • Yasuo Sugano

  • Takahiro Ohara

  • Toshihisa Anzai

  • Masafumi Kitakaze

Medical Centers

  • National Cerebral and Cardiovascular Center, Suita, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left ventricular diastolic dysfunction

Biomarkers

  • B-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved